Back to Dashboard
JNJ · Healthcare

JOHNSON & JOHNSON

USA Healthcare Filing: 2025-12-31
Smart-money confidence · 1 of 3 sources firing
Moderate — mixed signals

No standout activity across the feeds we track.

Hedge funds
64
Congress
0
Insiders
50
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Limited info. JOHNSON & JOHNSON is not currently in our model portfolio, but 11 tracked investors hold it. We're showing what we know from their latest 13F filings.
Market cap
$598.0B
Industry
Drug Manufacturers - General
Exchange
NYSE
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of…
11
Investors
0
New positions
3
Increasing
7
Decreasing
1
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Gotham Asset Mgmt (Greenblatt)
Trust weight: 1.1×
Increased +12%
% of portfolio
0.2%
Position change
+12%
0.2% of Gotham Asset Mgmt's portfolio
Millennium Management (Englander)
Trust weight: 1.0×
Increased +48%
% of portfolio
0.1%
Position change
+48%
0.1% of Millennium Management's portfolio
Point72 (Steve Cohen)
Trust weight: 1.1×
Increased +1532%
% of portfolio
0.0%
Position change
+1532%
0.0% of Point72's portfolio
Tweedy Browne
Trust weight: 1.2×
Decreased −2%
% of portfolio
3.9%
Position change
−2%
3.9% of Tweedy Browne's portfolio
Markel Group (Tom Gayner)
Trust weight: 1.4×
Unchanged
% of portfolio
1.2%
Position change
—
1.2% of Markel Group's portfolio
Bridgewater Associates (Dalio)
Trust weight: 1.3×
Decreased −23%
% of portfolio
1.0%
Position change
−23%
1.0% of Bridgewater Associates's portfolio
AQR Capital Management
Trust weight: 1.0×
Decreased −10%
% of portfolio
0.4%
Position change
−10%
0.4% of AQR Capital Management's portfolio
Elliott Investment Mgmt
Trust weight: 1.3×
Decreased −8%
% of portfolio
0.3%
Position change
−8%
0.3% of Elliott Investment Mgmt's portfolio
Polen Capital Management
Trust weight: 1.3×
Decreased −4%
% of portfolio
0.3%
Position change
−4%
0.3% of Polen Capital Management's portfolio
D.E. Shaw & Co
Trust weight: 1.0×
Decreased −23%
% of portfolio
0.1%
Position change
−23%
0.1% of D.E. Shaw & Co's portfolio
Citadel Advisors
Trust weight: 1.0×
Decreased −41%
% of portfolio
0.1%
Position change
−41%
0.1% of Citadel Advisors's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to JOHNSON & JOHNSON
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell JOHNSON & JOHNSON or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime
© 2026 Bogen Capital  ·  Not financial advice  ·  Data delayed up to 135 days Methodology  ·  Contact  ·  API